Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Qualigen Therapeutics Inc (QLGN)
NASDAQ:QLGN
Qualigen Therapeutics (QLGN) Stock Price & Analysis
540 Followers
QLGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.34 - $1.26
Previous Close$0.4
Volume79.81K
Average Volume (3M)60.13K
Market Cap
$2.07M
Enterprise Value$5.25M
Total Cash (Recent Filing)$1.30M
Total Debt (Recent Filing)$3.20M
Price to Earnings (P/E)-0.1
Beta0.32
Next Earnings
Mar 29, 2024EPS Estimate
-$0.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.58
Shares Outstanding5,181,058
10 Day Avg. Volume104,163
30 Day Avg. Volume60,132
Standard Deviation0.37
R-Squared0.01
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)-1.26
Price to Sales (P/S)0.42
Price to Cash Flow (P/CF)0.50
P/FCF Ratio0.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.87
Enterprise Value/Gross Profit1.05
Enterprise Value/Ebitda-0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Qualigen Therapeutics News
PremiumCompany Announcements
Qualigen Therapeutics Ends Deal with Pan-RAS Holdings
PremiumCompany Announcements
Qualigen Therapeutics Secures Investment and Expands Financing Options
PremiumCompany Announcements
Qualigen Therapeutics Inks Exclusive RAS Program Deal
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
QLGN FAQ
What was Qualigen Therapeutics Inc’s price range in the past 12 months?
Qualigen Therapeutics Inc lowest stock price was $0.34 and its highest was $1.26 in the past 12 months.
What is Qualigen Therapeutics Inc’s market cap?
Currently, no data Available
When is Qualigen Therapeutics Inc’s upcoming earnings report date?
Qualigen Therapeutics Inc’s upcoming earnings report date is Mar 29, 2024 which is 20 days ago.
How were Qualigen Therapeutics Inc’s earnings last quarter?
Qualigen Therapeutics Inc released its earnings results on Nov 14, 2023. The company reported -$0.72 earnings per share for the quarter, beating the consensus estimate of -$0.92 by $0.2.
Is Qualigen Therapeutics Inc overvalued?
According to Wall Street analysts Qualigen Therapeutics Inc’s price is currently Overvalued.
Does Qualigen Therapeutics Inc pay dividends?
Qualigen Therapeutics Inc does not currently pay dividends.
What is Qualigen Therapeutics Inc’s EPS estimate?
Qualigen Therapeutics Inc’s EPS estimate is -$0.52.
How many shares outstanding does Qualigen Therapeutics Inc have?
Qualigen Therapeutics Inc has 5,181,058 shares outstanding.
What happened to Qualigen Therapeutics Inc’s price movement after its last earnings report?
Qualigen Therapeutics Inc reported an EPS of -$0.72 in its last earnings report, beating expectations of -$0.92. Following the earnings report the stock price went up 5.714%.
Which hedge fund is a major shareholder of Qualigen Therapeutics Inc?
Currently, no hedge funds are holding shares in QLGN
---
Qualigen Therapeutics Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-55.05%
12-Months-Change
Fundamentals
Return on Equity
-321.20%
Trailing 12-Months
Asset Growth
-81.20%
Trailing 12-Months
Company Description
Qualigen Therapeutics Inc
Ritter Pharmaceuticals, Inc. engages in the development of novel therapeutic products which modulate the human gut microbiome to treat digestive disorders and gastrointestinal diseases. It focuses on the development and commercialization of RP-G28. The company was founded by Andrew J. Ritter and Ira E. Ritter on March 29, 2004 and is headquartered in Los Angeles, CA.
---
Technical Analysis
---